These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 11743840)
21. Successful use of education and cost-based feedback strategies to reduce physician utilization of low-osmolality contrast agents in the cardiac catheterization laboratory. Ziskind AA; Portelli J; Rodriguez S; Stafford JL; Herzog WR; Knox JG; Vogel RA Am J Cardiol; 1994 Jun; 73(16):1219-21. PubMed ID: 8203344 [No Abstract] [Full Text] [Related]
22. Clinical decision making: from theory to practice. Three battles to watch in the 1990s. Eddy DM JAMA; 1993 Jul; 270(4):520-6. PubMed ID: 8320794 [No Abstract] [Full Text] [Related]
23. A physician survey of the effect of drug sample availability on physicians' behavior. Chew LD; O'Young TS; Hazlet TK; Bradley KA; Maynard C; Lessler DS J Gen Intern Med; 2000 Jul; 15(7):478-83. PubMed ID: 10940134 [TBL] [Abstract][Full Text] [Related]
24. Cost-effective treatment of depression. Solomon G JAMA; 1995 Jun; 273(23):1833-4. PubMed ID: 7776495 [No Abstract] [Full Text] [Related]
25. How can care for depression become more cost-effective? Sturm R; Wells KB JAMA; 1995 Jan; 273(1):51-8. PubMed ID: 7996651 [TBL] [Abstract][Full Text] [Related]
26. Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework. Alabbadi I; Crealey G; Turner K; Rafferty T; Keenan L; Murray P; McElnay JC Pharm World Sci; 2010 Feb; 32(1):43-51. PubMed ID: 19882233 [TBL] [Abstract][Full Text] [Related]
27. Training Physicians to Provide High-Value, Cost-Conscious Care: A Systematic Review. Stammen LA; Stalmeijer RE; Paternotte E; Oudkerk Pool A; Driessen EW; Scheele F; Stassen LP JAMA; 2015 Dec; 314(22):2384-400. PubMed ID: 26647260 [TBL] [Abstract][Full Text] [Related]
28. Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison. Hassell K; Atella V; Schafheutle EI; Weiss MC; Noyce PR Eur J Public Health; 2003 Mar; 13(1):18-23. PubMed ID: 12678309 [TBL] [Abstract][Full Text] [Related]
29. Clinical practice guidelines and the cost of care. A growing alliance. O'Brien JA; Jacobs LM; Pierce D Int J Technol Assess Health Care; 2000; 16(4):1077-91. PubMed ID: 11155829 [TBL] [Abstract][Full Text] [Related]
30. A study of factors associated with cost and variation in prescribing among GPs. Carthy P; Harvey I; Brawn R; Watkins C Fam Pract; 2000 Feb; 17(1):36-41. PubMed ID: 10673486 [TBL] [Abstract][Full Text] [Related]
31. New medicines in primary care: a review of influences on general practitioner prescribing. Mason A J Clin Pharm Ther; 2008 Feb; 33(1):1-10. PubMed ID: 18211610 [TBL] [Abstract][Full Text] [Related]
32. Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicines. Roberts SJ; Bateman DN; Smith JM Br J Gen Pract; 1997 Jan; 47(414):13-8. PubMed ID: 9115786 [TBL] [Abstract][Full Text] [Related]
33. Factors affecting the uptake of new medicines in secondary care - a literature review. Chauhan D; Mason A J Clin Pharm Ther; 2008 Aug; 33(4):339-48. PubMed ID: 18613851 [TBL] [Abstract][Full Text] [Related]
35. Evaluating physician awareness of common health care costs in the emergency department. Gandhi R; Stiell I; Forster A; Worthington J; Ziss M; Kitts JB; Malik R CJEM; 2018 Jul; 20(4):539-549. PubMed ID: 28659219 [TBL] [Abstract][Full Text] [Related]
36. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342 [TBL] [Abstract][Full Text] [Related]
37. NHS will publish national list of "low value" drugs to curb GPs' prescribing costs. Iacobucci G BMJ; 2017 Mar; 356():j1613. PubMed ID: 28360183 [No Abstract] [Full Text] [Related]
38. How the reimbursement system may influence physicians' decisions results from focus groups interviews in France. Huttin C; Andral J Health Policy; 2000 Nov; 54(2):67-86. PubMed ID: 11094264 [TBL] [Abstract][Full Text] [Related]
39. Cost identification of Nordic FLIRI, Nordic FLOX, XELIRI and XELOX in first-line treatment of advanced colorectal cancer in Sweden -- a clinical practice model approach. Pettersson K; Carlsson G; Holmberg C; Sporrong SK Acta Oncol; 2012 Sep; 51(7):840-8. PubMed ID: 22937953 [TBL] [Abstract][Full Text] [Related]
40. Improving the appropriateness of physician prescribing. Lexchin J Int J Health Serv; 1998; 28(2):253-67. PubMed ID: 9595343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]